16:02 Dec 20
Nectar Lifesciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Nectar Lifesciences Ltd.
84/100 High Financial Strength
Quality68/100 Affordable Valuation
Valuation66/100 Technically Moderately Bullish
TechnicalSWOT
Strength
11
Weakness
3
Opportunity
0
Threat
1
937.41
Market Cap (Cr)
87.39
PE Ratio
0.87
Price to Book Ratio
66.18
RSI
0.29 %
Net Profit Margin
SWOT
Download Our App On:
